Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Amgen shares positive late-stage results for Uplizna in generalised myasthenia gravis

The company said it is planning to file for US approval of the drug in this indication

- PMLiVE

Women in pharma

Iona Everson from PMGroup spoke to Ulrike Graefe-Mody, global head of retinal health at Boehringer Ingelheim, about her career path and how female representation in the industry has changed over...

- PMLiVE

AMICULUM earns EcoVadis silver award for second consecutive year

We are proud to announce that AMICULUM has achieved the silver award from EcoVadis, a global leader in sustainability assessments, for the second year running! Scoring 73 out of 100,...

Amiculum

- PMLiVE

Pfizer’s Hympavzi granted FDA approval to treat haemophilia in adult and paediatric patients

More than 800,000 people globally are affected by the genetic blood disorder

- PMLiVE

J&J’s nipocalimab shows sustained disease control in adolescents with generalised myasthenia gravis

The severity of the rare autoimmune disease is heightened in paediatric patients

- PMLiVE

Jazz shares positive results for Zepzelca combination in phase 3 lung cancer study

Approximately 30,000 new cases of small cell lung cancer are reported in the US every year

- PMLiVE

Inizio Medical appoints Matt Wadyka as president, US medical affairs

Wadyka most recently served as global head of scientific communications at Roche/Genentech

- PMLiVE

Cultivating Interest in Infectious Disease Education at ID Week 2024

IDWeek starts tomorrow, October 16, and Medscape is bringing outcomes and education! We are excited to announce Medscape is presenting six posters that highlight the significant impact of our educational...

Medscape Education

- PMLiVE

Eli Lilly’s mirikizumab shows promise in phase 3 Crohn’s disease study

Inflammatory bowel disease affects almost one in every 100 people in the US

- PMLiVE

Merck and Exelixis partner to evaluate new cancer combination treatments

The companies will evaluate the regimens in head and neck cancer and renal cell carcinoma

- PMLiVE

FDA advisory committee recommends Stealth’s elamipretide for Barth syndrome

The ultra-rare genetic disease affects approximately 150 people in the US

- PMLiVE

Innovative Trials appoints new Leadership Team member

Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director

Innovative Trials

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links